Sepsis and Endotoxaemia in mice Stimulate the Expression of Interleukin-1 and Interleukin-6 in the Central Nervous System

1997 ◽  
Vol 92 (5) ◽  
pp. 519-525 ◽  
Author(s):  
Tory A. Meyer ◽  
Jing Jing Wang ◽  
Gregory M. Tiao ◽  
Cora K. Ogle ◽  
Josef E. Fischer ◽  
...  

1. In previous studies, experimental endotoxaemia was found to stimulate cytokine production in the central nervous system. The effect of sepsis on brain cytokines is not fully known. We compared the effect of endotoxaemia and sepsis on brain interleukin-1 and interleukin-6 expression. 2. Male A/J mice were injected subcutaneously with lipopolysaccharide (10 mg/kg) or an equal volume of saline as control. Sepsis was induced by caecal ligation and puncture (CLP); control mice underwent sham-operation. Brain tissue was assayed for interleukin-1 and interleukin-6 by ELISA. Northern blotting or the polymerase chain reaction was used to determine cytokine mRNA levels. 3. Administration of endotoxin induced a greater than fourfold increase in brain interleukin-1, a greater than threefold increase in interleukin-6 and an increase in mRNA for both cytokines. Caecal ligation and puncture resulted in increased brain interleukin-1 and interleukin-6 levels, but the changes were less pronounced and occurred later than after injection of endotoxin. There was no detectable difference in brain interleukin-1 mRNA between septic and sham-operated mice, whereas interleukin-6 mRNA was increased in brains of septic animals. 4. Sepsis and endotoxaemia resulted in similar, although not identical, changes in brain interleukin-1 and interleukin-6 concentrations and mRNA levels, suggesting that increased cytokine production in the central nervous system is part of the systemic response to sepsis and may be mediated by endotoxin.

1994 ◽  
Vol 641 (1) ◽  
pp. 155-159 ◽  
Author(s):  
Daniele Bottai ◽  
Mercedes Garcia-Gil ◽  
Maria Luisa Zaccardi ◽  
Loredana Fineschi ◽  
Marcello Brunelli

1994 ◽  
Vol 64 ◽  
pp. 59
Author(s):  
Yasuko Tomozawa ◽  
Masabumi Minami ◽  
Kazuki Yabuuchi ◽  
Masamichi Satoh

1993 ◽  
Vol 265 (4) ◽  
pp. R834-R839 ◽  
Author(s):  
T. Nakamori ◽  
A. Morimoto ◽  
N. Murakami

We investigated the role of central corticotropin-releasing factor (CRF) in the development of cardiovascular and thermal responses induced by stress or by interleukin-1 beta (IL-1 beta) in free-moving rats. Intracerebroventricular (icv) injection of alpha-helical CRF9-41 (10 micrograms), a CRF receptor antagonist, significantly attenuated hypertension, tachycardia, and a rise in body temperature induced by cage-switch stress, a mild stress. However, icv injection of alpha-helical CRF9-41 (10 micrograms) had no effect on hypertension, tachycardia, or fever induced by intraperitoneal (ip) injection of IL-1 beta (2 micrograms/kg) or icv prostaglandin E2 (PGE2, 100 ng). In contrast, icv injection of alpha-helical CRF9-41 (10 micrograms) significantly attenuated hypertension, tachycardia, or fever induced by icv injection of IL-1 beta (20 ng). The present results suggest that central CRF has an important role in the development of the cage-switch stress-induced responses, but it does not seem to contribute to the hypertension, tachycardia, and fever induced by ip IL-1 beta or by central PGE2. However, it is possible that when IL-1 beta directly acts on the central nervous system, some of its actions are mediated by central CRF.


2003 ◽  
Vol 88 (9) ◽  
pp. 4379-4383 ◽  
Author(s):  
Kaj Stenlöf ◽  
Ingrid Wernstedt ◽  
Ted Fjällman ◽  
Ville Wallenius ◽  
Kristina Wallenius ◽  
...  

1990 ◽  
Vol 173 (2) ◽  
pp. 585-590 ◽  
Author(s):  
Akira Uehara ◽  
Toshikatsu Okumura ◽  
Shigeru Kitamori ◽  
Yuichi Takasugi ◽  
Masayoshi Namiki

Sign in / Sign up

Export Citation Format

Share Document